Other Affiliated Sites
Simplified Chinese
Traditional Chinese
About Hepalink
Group Profile
Corporate Philosophy
Milestones
Leadership Team
Scientific Advisory Board
Our Businesses
Heparin Business
Global Industrial Chain
Global Heparin Injections Business
Product Profile
CDMO Services
Innovative Drugs
Global Manufacturing
Company News
Investor Relations
Corporate Governance
Disclosures
Stock Information
IR Events
IR Contact
Join Us
Career Development
Contact Us
Create Value for Investors Through
Safe and Stable Operations
Corporate Governance
Disclosures
Stock Information
IR Events
IR Contact
Disclosures
A-Share Information
H-Share Information
Financial Reports
Announcements
2022.10.01
智信：关于召开2022年第二次临时股东大会的通知公告
2022.08.30
智信：独立董事关于控股股东及其他关联方占用公司资金、、、、公司对外担保情况的专项说明和...
2022.08.30
智信：半年度非经营性资金占用及其他关联资金往来情况汇总表
2022.08.30
智信：2022年半年度报告摘要
2022.07.21
智信：第五届董事会第二十次会议决议公告
2022.07.21
智信：2021年年度权益分派实施公告
2022.07.13
智信：2022年半年度业绩预告
2022.06.14
智信：智信2021年年度股东大会法律意见书
2022.06.14
智信：2021年年度股东大会决议公告
2022.05.11
智信：关于续聘会计师事务所的公告
第一页
上一页
15
16
17
18
19
下一页
最后一页
About Hepalink
Group Profile
Corporate Philosophy
Milestones
Leadership Team
Scientific Advisory Board
Our Businesses
Heparin Business
CDMO Services
Innovative Drugs
Global Manufacturing
Company News
Investor Relations
Corporate Governance
Disclosures
Stock Information
IR Events
IR Contact
Join Us
Career Development
Contact Us
Official WeChat Account
Legal Statement
·
Environmental Disclosure
Copyright © 2024 Hepalink Group. All Rights Reserved.
站点地图
